Soleus Capital Master Fund, L.P. 13D and 13G filings for ESSA Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-15 4:46 pm Purchase |
2025-04-15 | 13D | ESSA Pharma Inc. EPIX |
Soleus Capital Master Fund, L.P. | 2,262,026 5.100% |
2,262,026 (New Position) |
Filing |